11-56093791-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001003750.1(OR8I2):c.484G>T(p.Val162Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,613,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001003750.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151298Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000519 AC: 13AN: 250278Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 135218
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461754Hom.: 0 Cov.: 34 AF XY: 0.00000550 AC XY: 4AN XY: 727192
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151298Hom.: 0 Cov.: 32 AF XY: 0.0000271 AC XY: 2AN XY: 73920
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 06, 2024 | The c.484G>T (p.V162L) alteration is located in exon 1 (coding exon 1) of the OR8I2 gene. This alteration results from a G to T substitution at nucleotide position 484, causing the valine (V) at amino acid position 162 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at